The value of the data on these big repositories, a big part of that is that there is data from all over the world. And yet, researches an otof countries in the global south, they don't want to be disadvantaged by not being able to be credited for all that work. They need to be incentivied. It's not just about their careers, because if you do the big, exciting papers, you get big publications that can lead to grants, that can lead to patents. So all of that would really help these labs that are really under resource to begin with.
In surprise news this week, the US government announced its support for waiving patent protections for COVID-19 vaccines, in an effort to boost supplies around the world.As fewer than 1% of people living in low-income countries have received COVID-19 vaccines, it is hoped that this move is a major step towards addressing this inequity by allowing manufacturers to legally produce generic versions of vaccines. We discuss the next steps that need to be taken to make this a reality, and why there is opposition to the plan.
Also on the podcast, we look at another aspect of coronavirus inequity: the sharing of genomic data. Around the world, researchers are racing to upload SARS-CoV-2 genome sequences to repositories, to help in the fight against the pandemic. One popular data repository, GISAID, requires users to sign in and acknowledge those whose data they analyse. Although a growing faction of scientists from wealthy nations are calling for the removal of gatekeeping requirements, scientists in the global south are pushing back, arguing that this will deprive them of credit and chances to participate in big-data analyses.
News: In shock move, US backs waiving patents on COVID vaccines
News: Why some researchers oppose unrestricted sharing of coronavirus genome data
News: Scientists call for fully open sharing of coronavirus genome data
Science: Coronavirus sequence trove sparks frustration
New York Times: Pfizer Reaps Hundreds of Millions in Profits From Covid Vaccine
Washington Post: Poor countries may not be vaccinated until 2024. Here’s how to prevent that.
Subscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday.
Hosted on Acast. See acast.com/privacy for more information.